改善儿童高度骨髓瘤的结果:回顾性生存研究的见解
Sachin Kanwar1, Mohit Dhingra1, Duddukunta Vishal Reddy1
1Department of Orthopedics, All India Institute of Medical Sciences, Rishikesh, India.
Journal of clinical orthopaedics and trauma
|September 2, 2025
概括
新辅助化疗可以改善小儿骨髓瘤患者的生存率. 这项研究表明这是一个重要的预后因素,但需要进行更大规模的试验来证实这些发现.
科学领域:
- 儿童瘤学
- 骨的瘤
- 癌症研究
背景情况:
- 高度骨肉瘤是儿童和青少年的主要骨癌.
- 目前的治疗方法没有显著改善转移或耐化疗病例的生存率.
- 需要确定儿童骨髓瘤的预后因素.
研究的目的:
- 评估小儿骨肉瘤患者的生存结果.
- 确定影响整体生存的预后因素.
- 在第三级护理中心分析治疗的有效性.
主要方法:
- 儿童骨肉瘤患者 (≤18岁) 的回顾性队列研究.
- 不包括二次性,外骨性或缓解性病例.
- 使用基平方,t测试和Cox比例危险模型的统计分析.
主要成果:
- 新辅助化疗与改善的生存率有显著的关联 (p=0. 043).
- 肢体救生手术和广泛的差距显示出有利的趋势.
- 在新辅助化疗 (HR 0.50) 和肢体救生手术 (HR 0.32) 中观察到较低的死亡风险比率.
结论:
- 新辅助化疗似乎可以提高儿童骨髓瘤的存活率.
- 这项研究支持新辅助化疗的预后价值.
- 需要进行更大规模的前性研究来验证发现并指导个性化治疗.
相关概念视频
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


